Allergan Plc (AGN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

MORRIS CORPORATE CENTER III PARSIPPANY, NJ 07054

Watson Pharmaceuticals, Inc. (Watson) is a specialty pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of brand and generic (off-patent) pharmaceutical products. Watson operates manufacturing, distribution, research and development (R&D), and administrative facilities in the United States of America. Watson operates and manages its business as three operating segments: Generic, Brand and Distribution. As of December 31, 2009, the Company marketed approximately 170 generic pharmaceutical product families and 30 brand pharmaceutical product families and distributed approximately 8,000 stock-keeping units (SKUs) through its Distribution business in the United States.
Actavis is a pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic and brand pharmaceutical products. Co. operates its business in the following operating segments: Global Generics, which is engaged in the development, manufacturing and sale of generic pharmaceutical products; Global Brands, which markets a number of products, including Androderm, Gelnique, and INFeD, among others; and Distribution, which distributes generic and selected brand pharmaceutical products, vaccines, injectables and over-the-counter medicines to independent pharmacies, alternate care providers, pharmacy chains and physicians' offices.

Data based on most recent fiscal year report
Market Cap54.789 Billion Shares Outstanding332.58 Million Avg Volume4.732 Million
1-Yr BETA vs S&P TR Current Ratio1.16 Quick Ratio1.06

Are you looking for this stock instead?

View SEC Filings from AGN instead.
Q2 2019 All Institutions Hedge Funds 1
To trade AGN now:
Filers who had this stock in their top 10: 48 25 (2.58%)
13F Filers holding this stock: 935 124 (12.81%)
Aggregate 13F shares on 06/30/2019: 263.525 Million 39.049 Million
Aggregate 13F shares on 03/31/2019: 263.908 Million 28.237 Million
Percent change: -0.15% 38.29%
Funds creating new positions: 147 48
Funds Adding to an existing position: 261 43
Funds closing out their position: 162 29
Funds reducing their position: 410 28
Heat Map Ranking for 06/30/2019 13
Heat Map Ranking for 03/31/2019 59
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AGN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PAONESSA ALBERT III

  • Director
45,945 2019-09-09 0

HILADO MARIA TERESA

  • Director
1,346 2019-08-31 0

TAYLOR RONALD R

  • Director
19,855 2019-08-20 0

COUGHLIN CHRISTOPHER J

  • Director
4,183 2019-07-30 1

DAVIDSON CAROL ANTHONY

  • Director
3,000 2019-07-30 1

LING KAREN EXECUTIVE VICE PRESIDENT

  • Officer
0 2019-07-29 2

HOWSON TAMAR D

  • Director
0 2019-07-01 0

WEISS FRED G

  • Director
71,440 2019-06-18 0

SCHAISON PHILIPPE

  • Director
63,145 2019-06-14 0

MEURY WILLIAM

0 2019-06-10 2

BLOEM JAMES H

  • Director
304,531 2019-06-05 0

BROWN ADRIANE M

  • Director
878 2019-05-30 1

FREYMAN THOMAS C

  • Director
19,988 2019-05-23 1

O'SULLIVAN PATRICK J

  • Director
0 2019-05-20 0

OLAFSSON SIGURDUR O

  • Director
0 2019-05-09 0

BISARO PAUL EXECUTIVE CHAIRMAN

  • Officer
  • Director
29,454 2019-05-07 0

STEWART ROBERT A PRESIDENT AND CEO

  • Officer
  • Director
78,668 2019-05-07 0

BODINE CHRIS W

  • Director
19,606 2019-04-30 1

KLEMA CATHY

  • Director
25,081 2019-04-30 2

BASGOZ NESLI

  • Director
8,207 2019-04-30 1

MCDONNELL PETER J

  • Director
7,343 2019-04-30 1

BOCCUZI JOSEPH H

  • Director
4,596 2019-04-30 2

GREENBERG MICHAEL ELDON

  • Director
2,684 2019-04-30 1

HUGIN ROBERT J

  • Director
5,285 2019-04-30 3

SAUNDERS BRENT L CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
167,909 2019-04-03 3

BAILEY A ROBERT D EVP CHIEF LEGAL OFF & CORP SEC

  • Officer
21,877 2019-04-03 2

NICHOLSON C. DAVID EVP CHIEF R&D OFFICER

  • Officer
15,336 2019-04-03 2

FRIDRIKSDOTTIR HAFRUN EXECUTIVE VP, GLOBAL R&D

  • Officer
16,750 2019-03-17 0

SWANTON WAYNE R EVP, GLOBAL OPERATIONS

  • Officer
13,028 2019-03-15 5

DARECCA JAMES SVP CHIEF ACCOUNTING OFFICER

  • Officer
7,033 2019-03-07 4

WALSH MATTHEW M EVP, CHIEF FINANCIAL OFFICER

  • Officer
24,181 2019-02-20 2

BUCHEN DAVID A SVP, CHIEF LEGAL OFFICER

  • Officer
0 2019-01-03 0

PRINCEN MARC EVP AND PRESIDENT INT'L COMML

  • Officer
11,790 2017-05-04 0

GALLAGHER MICHAEL R

  • Director
No longer subject to file 2017-05-03 0

NAVARRE PAUL EVP, PRESIDENT INT'L BRANDS

  • Officer
No longer subject to file 2016-06-08 0

WILKINSON GEORGE FRED CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
464,862 2016-04-29 0

TURNER ANDREW L

  • Director
No longer subject to file 2015-03-17 0

MICHAL JIRI

  • Director
No longer subject to file 2015-03-17 0

KING JOHN A

  • Director
No longer subject to file 2015-03-17 0

MAYR CHARLES M CHIEF COMMUNIC OFFICER

  • Officer
15,037 2015-03-05 0

JOYCE R TODD CHIEF FINANCIAL OFFICER

  • Officer
0 2014-07-01 0

EBERT CHARLES D SVP, BRANDS R&D

  • Officer
7,611 2013-11-06 0

EAGAN PATRICK CHIEF HR OFFICER-GLOBAL

  • Officer
7,009 2013-11-04 0

MICHELSON JACK

  • Director
No longer subject to file 2013-10-01 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments